| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2005;79:1072-1080
© 2005 The Society of Thoracic Surgeons
a Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, the Harvard-MIT Division of Health Sciences and Technology, Boston, Massachusetts
b Abramson Pediatric Research Center, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania
* Address reprint requests to Dr Schoen, Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (E-mail: fschoen{at}partners.org).
Calcification plays a major role in the failure of bioprosthetic and other tissue heart valve substitutes. Tissue valve calcification is initiated primarily within residual cells that have been devitalized, usually by glutaraldehyde pretreatment. The mechanism involves reaction of calcium-containing extracellular fluid with membrane-associated phosphorus to yield calcium phosphate mineral deposits. Calcification is accelerated by young recipient age, valve factors such as glutaraldehyde fixation, and increased mechanical stress. Recent studies have suggested that pathologic calcification is regulated by inductive and inhibitory factors, similar to the physiologic mineralization of bone. The most promising preventive strategies have included binding of calcification inhibitors to glutaraldehyde fixed tissue, removal or modification of calcifiable components, modification of glutaraldehyde fixation, and use of tissue cross linking agents other than glutaraldehyde. This review summarizes current concepts in the pathophysiology of tissue valve calcification, including emerging concepts of endogenous regulation, progress toward prevention of calcification, and issues related to calcification of the aortic wall of stentless bioprosthetic valves.
Related Article
Ann. Thorac. Surg. 2005 79: 905-910.
This article has been cited by other articles:
|
|
 |
|
  P. H. Stone Current selection of optimal prosthetic aortic valve replacement in middle-aged patients: still dealer's choice. J. Am. Coll. Cardiol., November 10, 2009; 54(20): 1869 - 1871. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Verbrugghe, B. Meuris, W. Flameng, and P. Herijgers Reconstruction of atrioventricular valves with photo-oxidized bovine pericardium Interactive CardioVascular and Thoracic Surgery, November 1, 2009; 9(5): 775 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tudorache, S. Kostin, T. Meyer, O. Teebken, C. Bara, A. Hilfiker, A. Haverich, and S. Cebotari Viable vascularized autologous patch for transmural myocardial reconstruction Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 306 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Caprili, A. N. Fahim, C. Zussa, and D. M. Cristell Very early malfunction of a large stentless aortic valve Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 417 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kalejs, P. Stradins, R. Lacis, I. Ozolanta, J. Pavars, and V. Kasyanov St Jude Epic heart valve bioprostheses versus native human and porcine aortic valves - comparison of mechanical properties Interactive CardioVascular and Thoracic Surgery, May 1, 2009; 8(5): 553 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Chen, J. Hermiller, A. K. Sinha, M. Sturek, L. Zhu, and G. S. Kassab Effects of stent sizing on endothelial and vessel wall stress: potential mechanisms for in-stent restenosis J Appl Physiol, May 1, 2009; 106(5): 1686 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pibarot and J. G. Dumesnil Prosthetic Heart Valves: Selection of the Optimal Prosthesis and Long-Term Management Circulation, February 24, 2009; 119(7): 1034 - 1048. [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Monzack, X. Gu, and K. S. Masters Efficacy of Simvastatin Treatment of Valvular Interstitial Cells Varies With the Extracellular Environment Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Schoen Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering Circulation, October 28, 2008; 118(18): 1864 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Izutani, T. Shibukawa, J. Kawamoto, S. Mochiduki, and D. Nishikawa Early Aortic Bioprosthetic Valve Deterioration in an Octogenarian Ann. Thorac. Surg., October 1, 2008; 86(4): 1369 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pettenazzo, M. Valente, and G. Thiene Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 418 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Fiore, M. Rodefeld, M. Turrentine, P. Vijay, T. Reynolds, J. Standeven, K. Hill, J. Bost, D. Carpenter, C. Tobin, et al. Pulmonary Valve Replacement: A Comparison of Three Biological Valves Ann. Thorac. Surg., May 1, 2008; 85(5): 1712 - 1718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Bosse, P. Mathieu, and P. Pibarot Genomics: The Next Step to Elucidate the Etiology of Calcific Aortic Valve Stenosis J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1327 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Goetz, T. E. Tan, K. H. Lim, S. L. H. Salgues, N. Grousson, F. Xiong, Y. L. Chua, and J. H. Yeo Truly stentless molded autologous pericardial aortic valve prosthesis with single point attached commissures in a sheep model Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 548 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Walther, J. Kempfert, M. A. Borger, J. Fassl, V. Falk, J. Blumenstein, M. Dehdashtian, G. Schuler, and F. W. Mohr Human Minimally Invasive Off-Pump Valve-in-a-Valve Implantation Ann. Thorac. Surg., March 1, 2008; 85(3): 1072 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text]
|
|
|
|
 |
|
 P. C Santos, L. R Gerola, I. Casagrande, E. Buffolo, and D. T Cheung Stentless Valves Treated by the L-Hydro Process in the Aortic Position in Sheep Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): 413 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Weber, J. Jouan, A. Matsunaga, E. Pettenazzo, T. Joudinaud, G. Thiene, and C. M.G. Duran Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cebotari, A. Lichtenberg, I. Tudorache, A. Hilfiker, H. Mertsching, R. Leyh, T. Breymann, K. Kallenbach, L. Maniuc, A. Batrinac, et al. Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells Circulation, July 4, 2006; 114(1_suppl): I-132 - I-137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vesely Heart Valve Tissue Engineering Circ. Res., October 14, 2005; 97(8): 743 - 755. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
